These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2580149)

  • 21. Vasoactive effects of serotonin on proximal coronary arteries in awake dogs.
    Chu A; Cobb FR
    Circ Res; 1987 Nov; 61(5 Pt 2):II81-7. PubMed ID: 3664987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.
    Apperley E; Feniuk W; Humphrey PP; Levy GP
    Br J Pharmacol; 1980 Feb; 68(2):215-24. PubMed ID: 7357206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of 5-HT receptors in simian isolated gastroepiploic artery.
    Noguchi M; Nakane T; Chiba S
    Eur J Pharmacol; 1993 Mar; 234(1):101-7. PubMed ID: 8472752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo.
    Lamping KG; Dole WP
    Circ Res; 1987 Dec; 61(6):904-13. PubMed ID: 3677343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor.
    Villalón CM; Centurión D; Luján-Estrada M; Terrón JA; Sánchez-López A
    Br J Pharmacol; 1997 Apr; 120(7):1319-27. PubMed ID: 9105708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation.
    McLennan PL; Taylor DA
    Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.
    Toda N; Okamura T
    J Pharmacol Exp Ther; 1990 May; 253(2):676-82. PubMed ID: 2338652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover.
    Roth BL; Nakaki T; Chuang DM; Costa E
    Neuropharmacology; 1984 Oct; 23(10):1223-5. PubMed ID: 6521858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin.
    Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of 5-hydroxytryptamine-induced contractile responses via 5-hydroxytryptamine receptors and alpha-adrenoceptors in dog mesenteric artery and vein.
    Shimamoto H; Shimamoto Y; Kwan CY; Daniel EE
    J Pharmacol Exp Ther; 1994 Feb; 268(2):779-84. PubMed ID: 8113990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large and small vessel responses to serotonin in the peripheral circulation.
    Hollenberg NK
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S89-91. PubMed ID: 2412068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal hemodynamic responses to 5-hydroxytryptamine (5-HT): involvement of the 5-HT receptor subtypes in the canine kidney.
    Shoji T; Tamaki T; Fukui K; Iwao H; Abe Y
    Eur J Pharmacol; 1989 Nov; 171(2-3):219-28. PubMed ID: 2576001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor.
    Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 2000 Oct; 53(3):353-7. PubMed ID: 11113592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms involved in the vasodilator action of 5-hydroxytryptamine in the dog femoral arterial circulation in vivo.
    Phillips CA; Mylecharane EJ; Shaw J
    Eur J Pharmacol; 1985 Jul; 113(3):325-34. PubMed ID: 2931286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
    Meller ST; Lewis SJ; Brody MJ; Gebhart GF
    Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction.
    Selig WM; Bloomquist MA; Cohen ML; Fleisch JH
    Pulm Pharmacol; 1988; 1(2):93-9. PubMed ID: 2980293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of chronic stellectomy on reactivity to serotonin in the dog external carotid bed.
    Mena MA; Vidrio H; Burkle G
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):110-6. PubMed ID: 4004413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional vascular effects of serotonin and ketanserin in young, healthy subjects.
    Blauw GJ; van Brummelen P; Chang PC; Vermeij P; van Zwieten PA
    Hypertension; 1988 Mar; 11(3):256-63. PubMed ID: 2832328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.